StemCell Therapy

LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Companys research report on the single-cell analysis market, the growing focus on personalized medicine across the globe is contributing to the growth of the single-cell analysis market. Personalized medicine is a medical practice that uses the genetic profile of a particular individual to make decisions for the treatment of a disease and also for the prevention and diagnosis of the disease for that specific individual. The single-cell analysis could help in the treatment of various diseases by giving deep insights into the needs of individual patients, the nature of the disease, and the personalized treatment for them. Thus, more patients are opting for personalized medicine for themselves. For example, according to the survey conducted in July 2021, by Dosis, a dosing platform provider, of 1,000 people, 85% of patients think that personalized medicine will improve care for them and 80% of patients think that personalized medicine should be available for all. Hence, the increasing focus on personalized medicine is supporting the growth of the market.

Request for a sample of the global single-cell analysis market report

The global single-cell analysis market size is expected to grow from $2.58 billion in 2021 to $2.9 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The single-cell analysis industry growth is expected to reach $4.9 billion in 2026 at a CAGR of 14.1%.

Companies in the single-cell analysis market are focusing on technological advancements to deliver intact and viable single cells. With the help of technological advancements, companies in the market are maintaining sample integrity through shipping, storage, and processing, increasing the recovery rates of delicate cells and also eliminating the need for specialized instruments. For example, in October 2021, PerkinElmer, a US-based company engaged in diagnostics, food, environmental and industrial testing, and life science research, along with Honeycomb Biotechnologies, a US-based company involved in single-cell genomic analysis, launched HIVE scRNAseq solution, which is a portable, single-use, and handheld device that allows gentle capture, robust storage, and ease of processing for the analysis of single-cell samples. It has RNA-Seq libraries from a variety of cell types, including fragile and labile cells such as granulocytes, nephrons, hepatocytes, and neurons. The HIVE system is simple to use and offers potential for laboratories conducting fundamental, translational, clinical, and preclinical research.

Major players in the single-cell analysis market are Becton, Dickinson and Company, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific Inc., Illumina Inc., Fluidigm Corporation, 10X Genomics, Bio-Rad Laboratories, Novogene Corporation, Agilent Technologies Inc., Sartorius AG, Luminex Corporation, Fluxion Biosciences, and Oxford Nanopore Technologies.

The global single-cell analysis market analysis is segmented by product into consumables, instruments; by workflow into single-cell isolation and library preparation, downstream analysis, data analysis; by technique into flow cytometry, next generation sequencing, Polymerase Chain Reaction (PCR), microscopy, mass spectrometry, others; by application into cancer, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization, others; by end-user into academic and research laboratories, biotechnology and pharmaceutical companies, hospital and diagnostic laboratories.

North America was the largest region in the single-cell analysis market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in TBRCs single-cell analysis market outlook are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Single-Cell Analysis Global Market Report 2022 Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provide single-cell analysis market overviews, single-cell analysis market analyze and forecast market size and growth for the whole market, single-cell analysis market segments and geographies, single-cell analysis market trends, single-cell analysis market drivers, single-cell analysis market restraints, leading competitors revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors approaches.

Not the market you are looking for? Check out some similar market intelligence reports:

Metabolomics Global Market Report 2022 By Product & Service (Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism), By Metabolomics Instruments (Separation Techniques, Detection Techniques), By Metabolomics Bioinformatics Tools & Services (Bioinformatics Tools And Database, Bioinformatics Services) Market Size, Trends, And Global Forecast 2022-2026

Cancer Tumor Profiling Global Market Report 2022 By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray), By Process Type (Genomics, Proteomics, Epigenetics, Metabolomics), By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications) Market Size, Trends, And Global Forecast 2022-2026

Flow Cytometry Global Market Report 2022 By Type (Instruments, Reagents & Consumables, Software, Accessories, Services), By Technology (Cell-Based, Bead-Based), By End User (Hospitals And Clinics, Academia And Research Institutes, Pharmaceutical And Biotechnology Companies), By Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Haematology) Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The Worlds Most Comprehensive Database

The Business Research Companys flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Link:
The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's...

This entry was posted on July 17, 2022 at 1:46 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |